Clinical Trial Update: Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports safety and efficacy data for allogeneic NK cell therapy in patients with advanced hepatocellular carcinoma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Allogeneic NK cells therapy

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN